Wechselwirkungen · M-M-RVaxPro
M-M-RvaxPro powder and solvent for suspension for injection M-M-RvaxPro powder and solvent for suspension for injection in pre-filled syringe Measles, mumps and rubella vaccine (live) · Abschnitt 4.5 · PDF-Seite 6
HOS-114022 · Präparat HOS-094015
Based on clinical studies with the quadrivalent measles, mumps, rubella and varicella vaccine and with the previous formulation of the combined measles, mumps and rubella vaccine manufactured by MSD, M-M-RvaxPro can be given concomitantly with a hepatitis A vaccine. In these clinical studies, it was demonstrated that the immune responses were unaffected and that the overall safety profiles of the administered vaccines were similar.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-30T16:34:00Z · SHA-256 1f84b715b09e24aaf9cb7a48ff222d83aa13b8cc05114993c41c6a61cefc89b7 · Passage eac53bf9c1ab8fbd01a558a2e0a3d312c4d3aefe170f052837152e6eda79dffb · Zeichen 1524–1959 im Abschnitt